pembrolizumab
merck
['pembro', 'key,note,789', 'sclc', 'lcsm,(-blcsm)', 'nsclc']
 #keynote789 trial at #asco23 #lcsm showing no benefit in os in platinum/pem with pembro vs no ici for tki-resistant egfr mutant #nsclc mpfs: 5.6 vs 5.5 mos, hr- 0.8 mos: 15.9 vs 14.7 mos, hr-0.84 
Physician | Chief Fellow @McGovernHemeOnc| IM- @UMassChan @baystateIM l Interests: thoracic oncology #LCSM, #globaloncology, #meded, SCD | Tweets are mine